Application

OVY

Aima Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97808584
Filing Date: 02/23/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97808584
MARK INFORMATION
*MARK OVY
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT OVY
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Aima Inc.
INTERNAL ADDRESS Suite 3200
*MAILING ADDRESS 650 West Georgia Street
*CITY Vancouver, BC
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Canada
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
V6B4P7
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Canada
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 003 
*IDENTIFICATION Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis; body and beauty care cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for cosmetic purposes; cannabis-based cosmetics; CBD cosmetics
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2226891
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 12/07/2022
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 009 
*IDENTIFICATION Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or medical information to provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and qualification.
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2226891
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 12/07/2022
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 005 
*IDENTIFICATION menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food and beverages for general health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of epilepsy; nutraceuticals for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical preparations for the prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely menstrual pain; vaginal suppositories for the prevention, treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological disorders, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation, muscle cramping or spasticity, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep duration, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids;
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 2226891
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Canada
       FOREIGN FILING DATE 12/07/2022
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Lisa M. Caldwell
ATTORNEY DOCKET NUMBER 22-109683-01
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Klarquist Sparkman, LLP
INTERNAL ADDRESS Suite 1600
STREET 121 SW Salmon Street
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 97204-2988
PHONE 503-595-5300
FAX 5035955301
EMAIL ADDRESS ptotmdocket@klarquist.com
OTHER APPOINTED ATTORNEY Andrew T. Ball, Lisa M. Caldwell, J. Christopher Carraway, Roy Chamcharas, Kristin L. Cleveland, Robert T. Cruzen, Amy C. Dachtler, Scott E. Davis, Caroline L. Desmond, James E. Geringer, Michael P. Girard, Susan W. Graf, Claire E. Green, Carsten C. Grellmann, Jeffrey B. Haendler, Klaus H. Hamm, Kevin M. Hayes, Joseph T. Jakubek, Sarah E. Jelsema, Alexa M. Johnston, Brandon J. Johnson, Cory A. Jones, Michael D. Jones, Deakin T. Lauer, Jie Lian, Jeffrey S. Love, Ziyu Ma, Andrew M. Mason, Gregory L. Maurer, Ethan A. McGrath, Tucker Mottl, Kyle B. Rinehart, Wayne R. Rupert, Sheree Lynn Rybak, Johanna P. Schwartz, Gregory K. Scott, Robert F. Scotti, Todd M. Siegel, Stacey C. Slater, Shelby A. Stepper, Samuel B. Thacker, Caitlin A. Thireault, Derrick W. Toddy, John D. Vandenberg, Mark W. Wilson, Garth A. Winn, and Travis Young, all members of the Bar of the State of Oregon
DOMESTIC REPRESENTATIVE INFORMATION
NAME Lisa M. Caldwell
FIRM NAME Klarquist Sparkman, LLP
INTERNAL ADDRESS Suite 1600
STREET 121 SW Salmon Street
CITY Portland
STATE Oregon
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 97204-2988
PHONE 503-595-5300
FAX 5035955301
EMAIL ADDRESS ptotmdocket@klarquist.com
CORRESPONDENCE INFORMATION
NAME Lisa M. Caldwell
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ptotmdocket@klarquist.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) lisa.caldwell@klarquist.com; mail@patentable.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 1050
*TOTAL FEES PAID 1050
SIGNATURE INFORMATION
SIGNATURE /Lanna Lastiwka/
SIGNATORY'S NAME Lanna Lastiwka
SIGNATORY'S POSITION CEO
DATE SIGNED 02/23/2023
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97808584
Filing Date: 02/23/2023

To the Commissioner for Trademarks:

MARK: OVY (Standard Characters, see mark)
The literal element of the mark consists of OVY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Aima Inc., a corporation of Canada, having an address of
      Suite 3200
      650 West Georgia Street
      Vancouver, BC V6B4P7
      Canada
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 003:  Body and beauty care cosmetics; body and beauty care cosmetics containing cannabinoids; body and beauty care cosmetics containing cannabis; body and beauty care cosmetics containing cannabis derivatives ; body creams for cosmetic purposes; body lotions for cosmetic purposes; cannabinoid oil for cosmetic purposes; cannabis oil for cosmetic purposes; cannabis-based cosmetics; CBD cosmetics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2226891, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 009:  Downloadable software in the nature of computer software or mobile application software for managing, analyzing and storing patient health or medical information to provide recommendations for products and services in the fields of health and wellbeing and to provide information about clinical trial and drug trial criteria and qualification.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2226891, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 005:  menstrual symptom treatment preparations; nutraceutical dietary supplement for maintaining general health and wellbeing; nutraceutical food and beverages for general health and well-being; nutraceuticals as a sleep aid; nutraceuticals for reducing stress and fatigue; nutraceuticals for relieving anxiety; nutraceuticals for the relief of epilepsy; nutraceuticals for the relief of pain; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment of pain; topical analgesic creams; Pharmaceutical preparations for the prevention of pain; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; suppositories for the prevention, treatment, or relief of pain; suppositories for the prevention, treatment, or relief of pain, namely menstrual pain; vaginal suppositories for the prevention, treatment, or relief of pain; vaginal suppositories for the prevention, treatment, or relief of pain, namely menstrual pain, pre-menstrual pain, peri-menopausal pain, menopausal pain and post-menopausal pain; pre-menstrual, peri-menopausal, menopausal, and post-menopausal symptom treatment preparations; pharmaceutical preparations for the prevention, treatment, or relief of pain, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the prevention, treatment, or relief of psychological disorders, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for the treatment, prevention, or relief of inflammation, muscle cramping or spasticity, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids; pharmaceutical preparations for improving sleep quality or sleep duration, namely tablets, capsules, suppositories, sublingual doses, extended release tablets, and liquids;
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Canada application number 2226891, filed 12/07/2022.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration. If ultimately the applicant does not rely on Section 44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Lisa M. Caldwell. Other appointed attorneys are Andrew T. Ball, Lisa M. Caldwell, J. Christopher Carraway, Roy Chamcharas, Kristin L. Cleveland, Robert T. Cruzen, Amy C. Dachtler, Scott E. Davis, Caroline L. Desmond, James E. Geringer, Michael P. Girard, Susan W. Graf, Claire E. Green, Carsten C. Grellmann, Jeffrey B. Haendler, Klaus H. Hamm, Kevin M. Hayes, Joseph T. Jakubek, Sarah E. Jelsema, Alexa M. Johnston, Brandon J. Johnson, Cory A. Jones, Michael D. Jones, Deakin T. Lauer, Jie Lian, Jeffrey S. Love, Ziyu Ma, Andrew M. Mason, Gregory L. Maurer, Ethan A. McGrath, Tucker Mottl, Kyle B. Rinehart, Wayne R. Rupert, Sheree Lynn Rybak, Johanna P. Schwartz, Gregory K. Scott, Robert F. Scotti, Todd M. Siegel, Stacey C. Slater, Shelby A. Stepper, Samuel B. Thacker, Caitlin A. Thireault, Derrick W. Toddy, John D. Vandenberg, Mark W. Wilson, Garth A. Winn, and Travis Young, all members of the Bar of the State of Oregon. Lisa M. Caldwell of Klarquist Sparkman, LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Suite 1600
      121 SW Salmon Street
      Portland, Oregon 97204-2988
      United States
      503-595-5300(phone)
      5035955301(fax)
      ptotmdocket@klarquist.com
The docket/reference number is 22-109683-01.
Lisa M. Caldwell submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Lisa M. Caldwell of Klarquist Sparkman, LLP
      121 SW Salmon Street
      Suite 1600
      Portland Oregon 97204-2988
      United States
      503-595-5300(phone)
      5035955301(fax)
      ptotmdocket@klarquist.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:
      Lisa M. Caldwell
       PRIMARY EMAIL FOR CORRESPONDENCE: ptotmdocket@klarquist.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): lisa.caldwell@klarquist.com; mail@patentable.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Lanna Lastiwka/   Date: 02/23/2023
Signatory's Name: Lanna Lastiwka
Signatory's Position: CEO
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 97808584
Payment Accounting Date: 02/23/2023

Serial Number: 97808584
Internet Transmission Date: Thu Feb 23 15:07:14 ET 2023
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20230223150714579
592-97808584-860c0ad0bfd952516eb1f4dfe2b
09545cbd4c7b493bac42dc1b4e2be0abaa6137-D
A-07148617-20230213145035383010

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed